Safety and clinical efficacy of AGT-181, a brain penetrating human insulin receptor antibody-iduronidase fusion protein, in a 26-week study with pediatric patients with mucopolysaccharidosis type I. Giugliani, R., Giugliani, L., Corte, A., D., Poswar, F., Donis, K., Schmidt, M., Hunt, D., Boado, R., J., & Pardridge, W., M. Molecular Genetics and Metabolism, 123(2):S54, 2, 2018.
Safety and clinical efficacy of AGT-181, a brain penetrating human insulin receptor antibody-iduronidase fusion protein, in a 26-week study with pediatric patients with mucopolysaccharidosis type I [link]Website  doi  bibtex   
@article{
 title = {Safety and clinical efficacy of AGT-181, a brain penetrating human insulin receptor antibody-iduronidase fusion protein, in a 26-week study with pediatric patients with mucopolysaccharidosis type I},
 type = {article},
 year = {2018},
 pages = {S54},
 volume = {123},
 websites = {https://linkinghub.elsevier.com/retrieve/pii/S1096719217309034},
 month = {2},
 id = {bc31d112-1137-36da-8d9c-d6b5f95eb336},
 created = {2020-02-15T13:15:24.728Z},
 file_attached = {false},
 profile_id = {a1b2ded6-b257-3e56-ac7c-9d438762d170},
 last_modified = {2021-10-19T17:30:55.232Z},
 read = {false},
 starred = {false},
 authored = {true},
 confirmed = {true},
 hidden = {false},
 private_publication = {false},
 bibtype = {article},
 author = {Giugliani, Roberto and Giugliani, Luciana and Corte, Amauri Dalla and Poswar, Fabiano and Donis, Karina and Schmidt, Mathias and Hunt, Douglas and Boado, Ruben J. and Pardridge, William M.},
 doi = {10.1016/j.ymgme.2017.12.128},
 journal = {Molecular Genetics and Metabolism},
 number = {2}
}

Downloads: 0